JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waters, C. M.
Right arrow Articles by Henthorn, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waters, C. M.
Right arrow Articles by Henthorn, T. K.

Vol. 288, Issue 1, 157-163, January 1999

Uptake of Fentanyl in Pulmonary Endothelium1

Christopher M. Waters, Michael J. Avram, Tom C. Krejcie and Thomas K. Henthorn

Departments of Anesthesiology and Biomedical Engineering, Northwestern University Medical School, Chicago, Illinois

Fentanyl is a basic amine shown to have extensive first-pass pulmonary uptake. To evaluate the role of the pulmonary endothelium in this uptake process, the simultaneous pharmacokinetics of [3H]fentanyl and two marker drugs, blue dextran, and [14C]antipyrine, were evaluated in a flow-through system of pulmonary endothelial cells. Fentanyl equilibrium kinetics were determined in a static culture system. The flow-through system consisted of monolayers of bovine pulmonary artery endothelial cells cultured on solid microcarrier beads placed in a chromatography column and perfused at 1.0 ml/min (37°C). Fentanyl and the markers were injected into the perfusate at the top of the column and samples were collected from the eluate at 9-s intervals for 10 min. The pharmacokinetic analyses were based on determinations of mean transit time and flow. Fentanyl was partitioned into the pulmonary endothelial cells 60 times more than the tissue water space marker antipyrine. In the static system, monolayers of bovine pulmonary artery endothelial cells were cultured in 3.8-cm2 wells to which were added 0 to 946 µmol (0-500 µg/ml) of unlabeled fentanyl citrate and 0.14 µmol of [3H]fentanyl. After a 10-min incubation, solubilized cells were assayed for [3H]fentanyl. Pulmonary endothelial cells contained a higher relative fentanyl concentration at lower fentanyl supernatant concentrations than would be expected if uptake occurred by diffusion alone. These observations can be explained with a model of fentanyl uptake that includes both passive diffusion and saturable active uptake. This suggests that the extensive first-pass pulmonary uptake of fentanyl observed in vivo is due largely to vascular endothelial drug uptake by both a passive and a saturable active uptake process.


0022-3565/99/2881-0157$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Anesth. Analg.Home page
I. A. Elkiweri, Y. L. Zhang, U. Christians, K.-Y. Ng, M. C. Tissot van Patot, and T. K. Henthorn
Competitive Substrates for P-Glycoprotein and Organic Anion Protein Transporters Differentially Reduce Blood Organ Transport of Fentanyl and Loperamide: Pharmacokinetics and Pharmacodynamics in Sprague-Dawley Rats
Anesth. Analg., January 1, 2009; 108(1): 149 - 159.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
L. M. Ferguson and G. B. Drummond
Acute effects of fentanyl on breathing pattern in anaesthetized subjects
Br. J. Anaesth., March 1, 2006; 96(3): 384 - 390.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
A. Dahan, A. Yassen, H. Bijl, R. Romberg, E. Sarton, L. Teppema, E. Olofsen, and M. Danhof
Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats
Br. J. Anaesth., June 1, 2005; 94(6): 825 - 834.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
F. Boer
Drug handling by the lungs
Br. J. Anaesth., July 1, 2003; 91(1): 50 - 60.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. K. Henthorn, Y. Liu, M. Mahapatro, and K.-y. Ng
Active Transport of Fentanyl by the Blood-Brain Barrier
J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1084 - 1089.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.